PerkinElmer is currently looking for
R&D Scientist with Bioaffinity Assay expertise
The Turku Site, with 550 employees, represents one of PerkinElmer’s major manufacturing and product development sites for newborn- and maternal fetal health screening. As the global market leader in newborn screening, our solutions have tested over 560 million babies worldwide for life-threatening diseases.
What we offer:
This position is permanent. Please apply by November 18th, 2018. For further information, please contact Teemu Korpimäki by e-mail email@example.com, or by telephone +358 40 3507 398 on Monday, November 5th between 13 – 15, or on Friday, November 9th between 9 – 11.
PerkinElmer Turku Site is a drug free site and a medical examination for new employees includes a drug test.